NFKB2 and cancer: The upstream regulatory role of the androgen receptor on the NF-κB2/p52 pathway in cancer-associated fibroblasts was elucidated and validated using CRISPR-Cas9, ChIP-qPCR, and dual-luciferase reporter assays.